352 related articles for article (PubMed ID: 2410768)
41. Differentiation of the open and closed states of the ionic channels of nicotinic acetylcholine receptors by tricyclic antidepressants.
Schofield GG; Witkop B; Warnick JE; Albuquerque EX
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5240-4. PubMed ID: 6272297
[TBL] [Abstract][Full Text] [Related]
42. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
[TBL] [Abstract][Full Text] [Related]
43. Thymopoietin inhibits function and ligand binding to nicotinic receptors at the neuromuscular junction.
Quik M; Collier B; Audhya T; Goldstein G
J Pharmacol Exp Ther; 1990 Sep; 254(3):1113-9. PubMed ID: 1967127
[TBL] [Abstract][Full Text] [Related]
44. Influence of the alcohol moiety of pyrethroids on their interactions with the nicotinic acetylcholine receptor.
Abbassy MA; Eldefrawi ME; Eldefrawi AT
J Toxicol Environ Health; 1983; 12(4-6):575-90. PubMed ID: 6321746
[TBL] [Abstract][Full Text] [Related]
45. The marine phycotoxin gymnodimine targets muscular and neuronal nicotinic acetylcholine receptor subtypes with high affinity.
Kharrat R; Servent D; Girard E; Ouanounou G; Amar M; Marrouchi R; Benoit E; Molgó J
J Neurochem; 2008 Nov; 107(4):952-63. PubMed ID: 18990115
[TBL] [Abstract][Full Text] [Related]
46. Forskolin acts as a noncompetitive inhibitor of nicotinic acetylcholine receptors.
Aylwin ML; White MM
Mol Pharmacol; 1992 May; 41(5):908-13. PubMed ID: 1588923
[TBL] [Abstract][Full Text] [Related]
47. Non-competitive effects of disopyramide at the neuromuscular junction: evidence for endplate ion channel block.
Jones SV; Marshall IG
Br J Anaesth; 1987 Jun; 59(6):776-83. PubMed ID: 2440467
[TBL] [Abstract][Full Text] [Related]
48. Parazoanthoxanthin A blocks Torpedo nicotinic acetylcholine receptors.
Rozman KB; Araoz R; Sepcić K; Molgo J; Suput D
Chem Biol Interact; 2010 Sep; 187(1-3):384-7. PubMed ID: 20230806
[TBL] [Abstract][Full Text] [Related]
49. Weakening of ion-channel interactions of Na+ and Li+ in acetylcholine-receptor channels of frog skeletal muscle with an increase in agonist concentration.
Manthey AA
Pflugers Arch; 1998 May; 435(6):818-26. PubMed ID: 9518511
[TBL] [Abstract][Full Text] [Related]
50. Nicotinic receptor inhibition by Tetraponera ant alkaloids.
Kem WR; Wildeboer K; LeFrancois S; Raja M; Marszalec W; Braekman JC
Cell Mol Neurobiol; 2004 Aug; 24(4):535-51. PubMed ID: 15233377
[TBL] [Abstract][Full Text] [Related]
51. Acetylcholine-evoked currents in cultured neurones dissociated from rat parasympathetic cardiac ganglia.
Fieber LA; Adams DJ
J Physiol; 1991 Mar; 434():215-37. PubMed ID: 1708819
[TBL] [Abstract][Full Text] [Related]
52. Interactions of chlordecone (kepone) and mirex with the nicotinic acetylcholine receptor--ion channel complex.
Aronstam RS; Hong JS
Toxicol Lett; 1986 Mar; 30(3):247-51. PubMed ID: 2422792
[TBL] [Abstract][Full Text] [Related]
53. Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells.
Ascher P; Large WA; Rang HP
J Physiol; 1979 Oct; 295():139-70. PubMed ID: 42780
[TBL] [Abstract][Full Text] [Related]
54. The ionic channel of the nicotinic acetylcholine receptor is unable to differentiate between the optical antipodes of perhydrohistrionicotoxin.
Spivak CE; Maleque MA; Takahashi K; Brossi A; Albuquerque EX
FEBS Lett; 1983 Nov; 163(2):189-93. PubMed ID: 6315487
[TBL] [Abstract][Full Text] [Related]
55. Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.
Ochoa EL; Li LA; Plummer A; McNamee MG
Mol Pharmacol; 1990 Dec; 38(6):863-71. PubMed ID: 2250665
[TBL] [Abstract][Full Text] [Related]
56. The non-competitive acetylcholinesterase inhibitor APS12-2 is a potent antagonist of skeletal muscle nicotinic acetylcholine receptors.
Grandič M; Aráoz R; Molgó J; Turk T; Sepčić K; Benoit E; Frangež R
Toxicol Appl Pharmacol; 2012 Dec; 265(2):221-8. PubMed ID: 23046821
[TBL] [Abstract][Full Text] [Related]
57. Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers.
Daly JW; Nishizawa Y; Edwards MW; Waters JA; Aronstam RS
Neurochem Res; 1991 Apr; 16(4):489-500. PubMed ID: 1922660
[TBL] [Abstract][Full Text] [Related]
58. Calcium channel effectors are potent non-competitive blockers of acetylcholine receptors.
Adam LP; Henderson EG
Pflugers Arch; 1990 Jul; 416(5):586-93. PubMed ID: 2172919
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors.
Boksa P; Quik M; Mitchell JB; Collier B; O'Neil W; Quirion R
Eur J Pharmacol; 1989 Nov; 173(1):93-108. PubMed ID: 2606158
[TBL] [Abstract][Full Text] [Related]
60. Interaction of narcotic antagonist naltrexone with nicotinic acetylcholine receptor.
Oliveira L; Madsen BW; Kapai N; Sherby SM; Swanson KL; Eldefrawi ME; Albuquerque EX
Eur J Pharmacol; 1987 Aug; 140(3):331-42. PubMed ID: 3653249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
